Shasunmed Life-Sciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 9.50 Cr
as on 14-12-2024
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -1261.55%
(FY 2023)
- Ebitda -1226.42%
(FY 2023)
- Net Worth 12970.87%
(FY 2023)
- Total Assets 914.45%
(FY 2023)
About Shasunmed Life-Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Abhaya Srisrimal and Umang Chordia serve as directors at the Company.
- CIN/LLPIN
U24290TN2021PTC147539
- Company No.
147539
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shasunmed Life-Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umang Chordia  | Director | 29-Oct-2021 | Current |
| Abhaya Srisrimal | Director | 29-Oct-2021 | Current |
Financial Performance and Corporate Structure Insights of Shasunmed Life-Sciences.
Shasunmed Life-Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1261.55% decrease in profit. The company's net worth Soared by an impressive increase of 12970.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shasunmed Life-Sciences?
Unlock access to Shasunmed Life-Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Venkata Narayana Active Ingredients Private LimitedActive 19 years 3 monthsAbhaya Srisrimal is a mutual person
Dhanvantari Nano Ayushadi Private LimitedActive 7 years 11 monthsAbhaya Srisrimal is a mutual person
Abusha Investment & Management Services LlpActive 10 years 8 monthsAbhaya Srisrimal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shasunmed Life-Sciences?
Shasunmed Life-Sciences has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shasunmed Life-Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shasunmed Life-Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
